Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;20(7):451-458.
doi: 10.1089/chi.2023.0125. Epub 2024 Jan 8.

Exploring Genetic Testing for Rare Disorders of Obesity: Experience and Perspectives of Pediatric Weight Management Providers

Affiliations

Exploring Genetic Testing for Rare Disorders of Obesity: Experience and Perspectives of Pediatric Weight Management Providers

Karyn J Roberts et al. Child Obes. 2024 Oct.

Abstract

Background: This study describes experiences and perspectives of pediatric weight management (PWM) providers on the implementation of genetic testing for rare causes of obesity. Methods: Purposive and snowball sampling recruited PWM providers via email to complete a 23-question survey with multiple choice and open-ended questions. Analyses include descriptive statistics, Fisher's exact test, one-way ANOVA with Tukey's post hoc test, and qualitative analysis. Results: Of the 55 respondents, 80% reported ordering genetic testing. Respondents were primarily physicians (82.8%) in practice for 11-20 years (42%), identified as female (80%), White (76.4%), and non-Hispanic (92.7%) and provided PWM care 1-4 half day sessions per week. Frequently reported patient characteristics that prompted testing did not vary by provider years of experience (YOE). These included obesity onset before age 6, hyperphagia, dysmorphic facies, and developmental delays. The number of patient characteristics that prompted testing varied by YOE (p = 0.03); respondents with 6-10 YOE indicated more patient characteristics than respondents with >20 YOE (mean 10.3 vs. mean 6.2). The reported primary benefit of testing was health information for patients/families; the primary drawback was the high number of indeterminate tests. Ethical concerns expressed were fear of increasing weight stigma, discrimination, and impact on insurance coverage. Respondents (42%) desired training and guidance on interpreting results and counseling patients and families. Conclusions: Most PWM providers reported genetic testing as an option for patient management. Provider training in genetics/genomics and research into provider and family attitudes on the genetics of obesity and the value of genetic testing are next steps to consider.

Keywords: genetic testing; genomic medicine; pediatric weight management, precision medicine; providers.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Hurtado AM, Acosta A. Precision medicine and obesity. Gastroenterol Clin North Am 2021;50(1):127–139; doi: 10.1016/j.gtc.2020.10.005 - DOI - PMC - PubMed
    1. Lehmann LS, Sulmasy LS, Burke W. Ethical considerations in precision medicine and genetic testing in internal medicine practice: A position paper from the American College of Physicians. Ann Intern Med 2022;175(9):1322–1323; doi: 10.7326/M22-0743 - DOI - PubMed
    1. Erdmann A, Rehmann-Sutter C, Bozzaro C. Patients' and professionals' views related to ethical issues in precision medicine: A mixed research synthesis. BMC Med Ethics 2021;22(1):116; doi: 10.1186/s12910-021-00682-8 - DOI - PMC - PubMed
    1. Scheuner MT, Sieverding P, Shekelle PG. Delivery of genomic medicine for common chronic adult diseases: A systematic review. JAMA 2008;299(11):1320–1334; doi: 10.1001/jama.299.11.1320 - DOI - PubMed
    1. Falahee M, Simons G, Raza K, et al. . Healthcare professionals' perceptions of risk in the context of genetic testing for the prediction of chronic disease: A qualitative metasynthesis. J Risk Res 2018;21(2):129–166; doi: 10.1080/13669877.2016.1153503 - DOI

LinkOut - more resources